High-Risk Hepatocellular Carcinoma: Hepatic Arterial Infusion Chemotherapy versus Transarterial Chemoembolization.
Baogen ZhangBiqing HuangFan YangJiandong YangMan KongJing WangYaoxian XiangKangjie WangRuchen PengKun YangChao AnDong YanPublished in: Journal of hepatocellular carcinoma (2024)
HAIC can provide better disease control for hHCC than cTACE, with a comparable long-term OS and safety.